RP
Riverbridge Partners’s Medpace MEDP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136M | Sell |
434,024
-47,102
| -10% | -$14.8M | 2.19% | 9 |
|
|
2025
Q1 | $147M | Sell |
481,126
-36,407
| -7% | -$11.1M | 2.35% | 8 |
|
|
2024
Q4 | $172M | Sell |
517,533
-34,111
| -6% | -$11.3M | 2.35% | 9 |
|
|
2024
Q3 | $184M | Buy |
551,644
+15,648
| +3% | +$5.22M | 2.46% | 8 |
|
|
2024
Q2 | $221M | Sell |
535,996
-70,254
| -12% | -$28.9M | 3% | 7 |
|
|
2024
Q1 | $245M | Sell |
606,250
-77,693
| -11% | -$31.4M | 2.99% | 4 |
|
|
2023
Q4 | $210M | Buy |
683,943
+43,036
| +7% | +$13.2M | 2.62% | 7 |
|
|
2023
Q3 | $155M | Sell |
640,907
-10,799
| -2% | -$2.61M | 2.12% | 13 |
|
|
2023
Q2 | $157M | Buy |
651,706
+211,011
| +48% | +$50.7M | 1.97% | 16 |
|
|
2023
Q1 | $82.9M | Sell |
440,695
-14,999
| -3% | -$2.82M | 1.16% | 31 |
|
|
2022
Q4 | $96.8M | Sell |
455,694
-11,143
| -2% | -$2.37M | 1.45% | 22 |
|
|
2022
Q3 | $73.4M | Buy |
466,837
+29,134
| +7% | +$4.58M | 1.09% | 28 |
|
|
2022
Q2 | $65.5M | Buy |
437,703
+103,524
| +31% | +$15.5M | 1.05% | 33 |
|
|
2022
Q1 | $54.7M | Buy |
334,179
+30,158
| +10% | +$4.93M | 0.62% | 59 |
|
|
2021
Q4 | $66.2M | Buy |
304,021
+11,340
| +4% | +$2.47M | 0.65% | 52 |
|
|
2021
Q3 | $55.4M | Sell |
292,681
-3,459
| -1% | -$655K | 0.56% | 65 |
|
|
2021
Q2 | $52.3M | Buy |
296,140
+13,429
| +5% | +$2.37M | 0.53% | 67 |
|
|
2021
Q1 | $46.4M | Buy |
+282,711
| New | +$46.4M | 0.53% | 64 |
|